These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28093650)

  • 1. Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a "real-world" study.
    Zhang Z; Zhai Z; Yang Y; Wan J; Xie W; Zhu J; Shen YH; Wang C
    J Thromb Thrombolysis; 2017 May; 43(4):540-549. PubMed ID: 28093650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: A real-world study in Chinese patients.
    Zhang Z; Lei J; Zhai Z; Yang Y; Wan J; Xie W; Wang C
    Clin Respir J; 2019 Mar; 13(3):139-147. PubMed ID: 30661286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of distal deep vein thrombosis.
    Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer levels enhance the discriminatory capacity of bleeding risk scores for predicting in-hospital bleeding events in acute pulmonary embolism.
    Skowrońska M; Furdyna A; Ciurzyński M; Pacho S; Bienias P; Palczewski P; Kurnicka K; Jankowski K; Lipińska A; Uchacz K; Karolak B; Pruszczyk P
    Eur J Intern Med; 2019 Nov; 69():8-13. PubMed ID: 31427186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2.
    Nishimoto Y; Yamashita Y; Morimoto T; Chatani R; Kaneda K; Ikeda N; Kobayashi Y; Ikeda S; Kim K; Inoko M; Takase T; Tsuji S; Oi M; Takada T; Otsui K; Sakamoto J; Ogihara Y; Inoue T; Usami S; Chen PM; Togi K; Koitabashi N; Hiramori S; Doi K; Mabuchi H; Tsuyuki Y; Murata K; Takabayashi K; Nakai H; Sueta D; Shioyama W; Dohke T; Nishikawa R; Sato Y; Watanabe T; Yamada T; Fukunami M; Kimura T;
    J Thromb Haemost; 2024 Oct; 22(10):2784-2796. PubMed ID: 38944241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
    Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
    Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
    Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
    JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
    Agnelli G; Prandoni P; Becattini C; Silingardi M; Taliani MR; Miccio M; Imberti D; Poggio R; Ageno W; Pogliani E; Porro F; Zonzin P;
    Ann Intern Med; 2003 Jul; 139(1):19-25. PubMed ID: 12834314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major bleeding in patients with pulmonary embolism presenting with syncope.
    Maestre A; Escribano JC; Lobo JL; Jara-Palomares L; Jiménez D; Bikdeli B; Armestar F; Bura-Riviere A; Lorenzo A; Monreal M;
    Eur J Clin Invest; 2022 Jul; 52(7):e13774. PubMed ID: 35302666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.
    Nijkeuter M; Söhne M; Tick LW; Kamphuisen PW; Kramer MH; Laterveer L; van Houten AA; Kruip MJ; Leebeek FW; Büller HR; Huisman MV;
    Chest; 2007 Feb; 131(2):517-23. PubMed ID: 17296656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
    Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial.
    Klok FA; Toenges G; Mavromanoli AC; Barco S; Ageno W; Bouvaist H; Brodmann M; Cuccia C; Couturaud F; Dellas C; Dimopoulos K; Duerschmied D; Empen K; Faggiano P; Ferrari E; Galiè N; Galvani M; Ghuysen A; Giannakoulas G; Huisman MV; Jiménez D; Kozak M; Lang IM; Lankeit M; Meneveau N; Münzel T; Palazzini M; Petris AO; Piovaccari G; Salvi A; Schellong S; Schmidt KH; Verschuren F; Schmidtmann I; Meyer G; Konstantinides SV;
    Lancet Haematol; 2021 Sep; 8(9):e627-e636. PubMed ID: 34363769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study - data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA).
    Monelli M; Molteni M; Cassetti G; Bagnara L; De Grazia V; Zingale L; Zilli F; Bussotti M; Totaro P; De Maria B; Dalla Vecchia LA
    Vasc Health Risk Manag; 2019; 15():19-25. PubMed ID: 30833810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
    Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of very early major bleeding risk in acute pulmonary embolism: an independent external validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction (PE-SARD) bleeding score.
    Villiger R; Méan M; Stalder O; Limacher A; Rodondi N; Righini M; Aujesky D
    J Thromb Haemost; 2023 Oct; 21(10):2884-2893. PubMed ID: 37149148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study.
    Marconi L; Carrozzi L; Aquilini F; Celi A; Pistelli F; Palla A
    Medicine (Baltimore); 2016 Aug; 95(34):e4364. PubMed ID: 27559946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis versus anticoagulation for the initial treatment of moderate pulmonary embolism: a meta-analysis of randomized controlled trials.
    Chen H; Ren C; Chen H
    Respir Care; 2014 Dec; 59(12):1880-7. PubMed ID: 25269681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
    Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M;
    Eur Respir J; 2016 Nov; 48(5):1360-1368. PubMed ID: 27660517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.